Vertex Pharmaceuticals Overview
Vertex Pharmaceuticals Target Price
Analysts' 12-month price predictions for VRTX.
Share Price
$445.87
Average Target Price
$445.00
0.2% downside
0.2% downside4 analysts in the last 4 months
High: $462 | Low: $424
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-05-07 | Raymond JamesChristopher Raymond | $456 |  2.3% upside |  |
| 2024-05-07 | RBC CapitalBrian Abrahams | $424 | 4.9% downside | |
| 2024-04-11 | H.C. WainwrightAndrew Fein | $462 | 3.6% upside | |
| 2024-04-11 | Evercore ISILiisa Bayko | $438 | 1.8% downside | |
| 2023-02-08 | Morgan Stanley | $285 | 36.1% downside | |
| 2023-02-08 | H.C. Wainwright | $326 | 26.9% downside | |
| 2023-02-08 | Leerink Partners | $365 | 18.1% downside | |
| 2022-11-17 | Argus Research | $340 | 23.7% downside | |
| 2022-08-08 | Morgan Stanley | $253 | 43.3% downside | |
| 2022-08-05 | H.C. Wainwright | $300 | 32.7% downside | |
| 2022-07-12 | Cantor FitzgeraldOlivia Brayer | $365 | 18.1% downside | |
| 2022-07-11 | Stifel NicolausPaul Matteis | $240 | 46.2% downside | |
| 2022-07-02 | Argus ResearchJasper Hellweg | $280 | 37.2% downside | |
| 2022-06-13 | Cowen & Co. | $310 | 30.5% downside | |
| 2022-05-03 | Morgan StanleyMatthew Harrison | $250 | 43.9% downside | |
| 2022-04-22 | Piper Sandler | $249 | 44.2% downside | |
| 2022-04-06 | OppenheimerHartaj Singh | $350 | 21.5% downside | |
| 2022-03-22 | Robert W. BairdBrian Skorney | $240 | 46.2% downside | |
| 2022-03-22 | BMO CapitalEvan Seigerman | $274 | 38.5% downside | |
| 2022-01-27 | JefferiesMichael Yee | $275 | 38.3% downside | |
| 2022-01-27 | J.P. MorganCory Kasimov | $288 | 35.4% downside | |
| 2022-01-27 | Morgan StanleyMatthew Harrison | $208 | 53.3% downside | |
| 2022-01-27 | Wolfe ResearchAndrew Galler | $282 | 36.8% downside | |
| 2022-01-24 | Cowen & Co.Phil Nadeau | $300 | 32.7% downside | |
| 2021-12-02 | Leerink PartnersGeoff Porges | $175 | 60.8% downside | |
| 2021-12-01 | GuggenheimDebjit Chattopadhyay | $286 | 35.9% downside | |
| 2021-11-02 | Bank of America SecuritiesGeoff Meacham | $275 | 38.3% downside | |
| 2021-06-11 | BarclaysGena Wang | $285 | 36.1% downside | |
| 2021-06-11 | Cantor FitzgeraldAlethia Young | $281 | 37% downside | |
| 2021-05-12 | UBSColin Bristow | $279 | 37.4% downside | |